Micro (mi) RNA and Diabetic Retinopathy
- PMID: 35873619
- PMCID: PMC9300788
- DOI: 10.1007/s12291-021-01018-4
Micro (mi) RNA and Diabetic Retinopathy
Abstract
Diabetic Retinopathy (DR), a debilitating microvascular complication of diabetes, is one of the leading cause of blindness. However, the pathogenesis of this disease is not fully understood. Few Studies have reported the role of MicroRNA (miRNA), which is deregulated or altered in many diseases. Further, few pathways linked genes which have been suggested to be regulated by miRNAs, may play an important role in the regulation of glucose homeostasis and eventually may contribute to the establishment of DR. However, the roles of microRNAs (miRNAs) in DR are still not very clear. In current review, we explored various findings of scientific database demonstrating the role of miRNA in the progression and development of Diabetic Retinopathy.
Keywords: Diabetic retinopathy; Glucose; Mi RNA.
© The Author(s), under exclusive licence to Association of Clinical Biochemists of India 2021.
Conflict of interest statement
Conflict of interestThere is no conflict of interest.
Figures

Similar articles
-
MicroRNA and diabetic retinopathy-biomarkers and novel therapeutics.Ann Transl Med. 2021 Aug;9(15):1280. doi: 10.21037/atm-20-5189. Ann Transl Med. 2021. PMID: 34532417 Free PMC article. Review.
-
Role of microRNAs in the modulation of diabetic retinopathy.Prog Retin Eye Res. 2014 Nov;43:92-107. doi: 10.1016/j.preteyeres.2014.07.003. Epub 2014 Aug 14. Prog Retin Eye Res. 2014. PMID: 25128741 Review.
-
Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy.Biosci Rep. 2017 Nov 29;37(6):BSR20171157. doi: 10.1042/BSR20171157. Print 2017 Dec 22. Biosci Rep. 2017. PMID: 29074557 Free PMC article. Review.
-
MicroRNAs: Potential Targets in Diabetic Retinopathy.Horm Metab Res. 2020 Mar;52(3):142-148. doi: 10.1055/a-1107-2943. Epub 2020 Mar 25. Horm Metab Res. 2020. PMID: 32215885 Review.
-
RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.Am J Physiol Endocrinol Metab. 2018 Sep 1;315(3):E374-E385. doi: 10.1152/ajpendo.00021.2018. Epub 2018 May 29. Am J Physiol Endocrinol Metab. 2018. PMID: 29812988
Cited by
-
miR-130a-3p enhances autophagy through the YY1/PI3K/AKT/mTOR signaling pathway to regulate macrophage polarization and alleviate diabetic retinopathy.J Diabetes Investig. 2025 Mar;16(3):392-404. doi: 10.1111/jdi.14381. Epub 2024 Dec 13. J Diabetes Investig. 2025. PMID: 39668747 Free PMC article.
-
Mir-509-3p targets SLC25A13 to regulate ferroptosis and protect retinal endothelial cells in diabetic retinopathy.Acta Diabetol. 2025 Jun;62(6):831-844. doi: 10.1007/s00592-024-02400-3. Epub 2024 Nov 7. Acta Diabetol. 2025. PMID: 39508857
-
Ginsenoside Rg1 inhibits angiogenesis in diabetic retinopathy through the miR-100-3p/FBXW7/c-MYC molecular axis.J Diabetes Investig. 2025 May;16(5):791-806. doi: 10.1111/jdi.70016. Epub 2025 Mar 3. J Diabetes Investig. 2025. PMID: 40033576 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources